Lawrence Madoff to Sensitivity and Specificity
This is a "connection" page, showing publications Lawrence Madoff has written about Sensitivity and Specificity.
Connection Strength
0.103
-
Suliman S, Matias WR, Fulcher IR, Molano FJ, Collins S, Uceta E, Zhu J, Paxton RM, Gonsalves SF, Harden MV, Fisher M, Meldrim J, Gabriel S, Franke MF, Hung DT, Smole SC, Madoff LC, Ivers LC. Evaluation of the Access Bio CareStart rapid SARS-CoV-2 antigen test in asymptomatic individuals tested at a community mass-testing program in Western Massachusetts. Sci Rep. 2022 Dec 09; 12(1):21338.
Score: 0.042
-
Pollock NR, Jacobs JR, Tran K, Cranston AE, Smith S, O'Kane CY, Roady TJ, Moran A, Scarry A, Carroll M, Volinsky L, Perez G, Patel P, Gabriel S, Lennon NJ, Madoff LC, Brown C, Smole SC. Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts. J Clin Microbiol. 2021 04 20; 59(5).
Score: 0.038
-
Barboza P, Vaillant L, Le Strat Y, Hartley DM, Nelson NP, Mawudeku A, Madoff LC, Linge JP, Collier N, Brownstein JS, Astagneau P. Factors influencing performance of internet-based biosurveillance systems used in epidemic intelligence for early detection of infectious diseases outbreaks. PLoS One. 2014; 9(3):e90536.
Score: 0.023